ORG Wealth Partners’s Novo Nordisk NVO Stock Holding History

ORG Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$336K	Hold	7,005	–	–	0.05%	193
2026 Q1	$257K	Hold	7,005	–	–	0.05%	192
2025 Q4	$356K	Sell	7,005 -20	-0.3%	-$1.02K	0.08%	149
2025 Q3	$390K	Buy	7,025 +6,800	+3,022%	+$398K	0.08%	148
2025 Q2	$15.7K	Sell	225 -83	-27%	-$5.65K	﹤0.01%	458
2025 Q1	$20.9K	Sell	308 -1,202	-80%	-$99.3K	0.01%	445
2024 Q4	$130K	Sell	1,510 -1,122	-43%	-$121K	0.04%	148
2024 Q3	$313K	Buy	+2,632	New	+$351K	0.1%	89

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

ORG Wealth Partners's NVO Position: Q2 2026 in Review

ORG Wealth Partners held its Novo Nordisk (NVO) position steady in Q2 2026 at 7,005 shares worth $336K. The position accounts for 0.05% of the portfolio, ranked #193.

ORG Wealth Partners first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $390K in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

ORG Wealth Partners held 7,005 shares of Novo Nordisk worth $336K as of Q2 2026.
ORG Wealth Partners left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.05% of ORG Wealth Partners's portfolio in Q2 2026, its #193 holding.
ORG Wealth Partners first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
ORG Wealth Partners's Novo Nordisk position peaked at $390K in Q3 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.